Home > News > Nano Killers Aim at Mini Tumors
June 22nd, 2004
Nano Killers Aim at Mini Tumors
A company called Kereos is developing a pair of nanotechnologies to identify tumors that measure just 1 mm in diameter, then kill them with a tiny but precise amount of a chemotherapy drug. The technologies, if approved by the Food and Drug Administration, would not only find cancers in their earliest stages before they can do damage or spread, but also deliver a small amount of a drug targeted directly at tumors, which would cause little or no side effects.
Return on investment for kit and promotion materials April 24th, 2014
University of Tehran Researchers Invent Non-Enzyme Sensor to Detect Blood Sugar April 23rd, 2014
Gold nanoparticles help target, quantify breast cancer gene segments in a living cell April 23rd, 2014
QuantuMDx announce prototype handheld lab for 15 minute malaria diagnosis and drug resistance testing April 23rd, 2014